Disease Cost Studies
-
Acute and lifetime costs of stroke
-
Alzheimer's disease progression: health and social care costs
-
Burden of illness associated with aneurysm sub-arachnoid haemorrhage
-
Coeliac disease: resource use and costs
- Resource use and costs associated with coeliac disease before and after diagnosis: a case control study
-
Combined anti-malarial and anti-bacterial suppository
- Economic case for a combined antimalarial-antibacterial rectal formulation for community use
-
CVD Costs in Europe: The economic burden of cardiovascular disease in the enlarged European Union
-
Dementia in the EU: Costs and Research Funding
-
Dementia in the UK: Costs and Research Funding
-
Economic case for a suppository intervention for treatment of neonatal sepsis in a community setting
-
Estimating the long-term economic costs of preterm birth
-
Health status and health-related quality of life preference-based outcomes of children aged 7-9 years with bilateral permanent childhood hearing impairment
-
Radon
- Economic evaluation of radon remediation
-
Resource Costs, Health Outcomes and Cost-effectiveness in stroke care: evidence from the Oxford Vascular Study
-
The economic burden of cerebrovascular diseases in the UK
-
The economic burden of heart failure
-
The economic burden of lung disease
-
The economic burden of malignant neoplasms in the European Union
-
The economic costs of bipolar disorder
